IGM Biosciences, Inc.
IGMSDelisted Aug 14, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496323
IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding IGM Biosciences, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 89 | 1 | 93 | +5 |
| Shares | 17.5M | 48 | 17.7M | +186.6K (+1.1%) |
| Value | $315.6M | $865 | $402.0M | +$86.4M (+27.4%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held IGM Biosciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 586,663 | $13.3M | 0.01% |
| Candriam Luxembourg S.C.A. | 48,760 | $1.11M | 0.01% |
| ExodusPoint Capital Management, LP | 25,485 | $580.0K | 0.01% |
| BNP Paribas Arbitrage, SA | 11,645 | $264.8K | 0.00% |
| Delphia (USA) Inc. | 10,185 | $232.0K | 0.26% |
| Corton Capital Inc. | 9,999 | $227.0K | 0.28% |
| State of Wisconsin Investment Board | 9,388 | $213.0K | 0.00% |
| Two Sigma Investments, LP | 9,281 | $211.0K | 0.00% |
| SG Americas Securities, LLC | 6,322 | $144.0K | 0.00% |
| Quantbot Technologies LP | 3,600 | $81.0K | 0.01% |
| Allspring Global Investments Holdings, LLC | 2,729 | $62.0K | 0.00% |
| Group One Trading, L.P. | 756 | $17.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 272 | $6.00K | 0.00% |
| Point72 Hong Kong Ltd | 238 | $5.00K | 0.00% |
| Cutler Group LP | 110 | $2.00K | 0.00% |
| Wipfli Financial Advisors LLC, | 108 | $2.00K | 0.00% |
| Parallel Advisors, LLC | 13 | $0 | 0.00% |
| Dark Forest Capital Management LP | 2 | $0 | 0.00% |
Sold out (13)
Institutions that held IGM Biosciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| HRT Financial LP | 70,661 | $1.27M |
| Ergoteles LLC | 38,500 | $694.0K |
| Jane Street Group, LLC | 20,110 | $363.0K |
| Caxton Associates LP | 19,009 | $343.0K |
| Bayesian Capital Management, LP | 16,900 | $305.0K |
| Fred Alger Management, LLC | 12,067 | $218.0K |
| Engineers Gate Manager LP | 11,531 | $208.0K |
| Alpha Paradigm Partners, LLC | 8,939 | $161.0K |
| STRS Ohio | 5,200 | $93.0K |
| Captrust Financial Advisors | 2,750 | $50.0K |
| Aquatic Capital Management LLC | 600 | $11.0K |
| State of Wyoming | 269 | $5.00K |
| Prospera Financial Services Inc | 98 | $2.00K |
Not filed for Q3 2022 yet (1)
Institutions that held IGM Biosciences, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exane Derivatives | 48 | $865 |